New approaches to anticancer drug design based on the inhibition of farnesyltransferase

1998 ◽  
Vol 3 (1) ◽  
pp. 26-33 ◽  
Author(s):  
Saïd M. Sebti ◽  
Andrew D. Hamilton
2019 ◽  
Vol 2019 ◽  
pp. 1-9
Author(s):  
Ayodele T. Odularu ◽  
Peter A. Ajibade ◽  
Johannes Z. Mbese

The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies. Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers). Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.


2019 ◽  
Vol 24 (9) ◽  
pp. 865-866
Author(s):  
Mariafrancesca Scalise ◽  
Veli-Pekka Jaakola

1997 ◽  
Vol 33 ◽  
pp. S173
Author(s):  
R. Allman ◽  
W.G. Jiang ◽  
P. Cowbum ◽  
M. Mason

2016 ◽  
Vol 11 (10) ◽  
pp. 957-968 ◽  
Author(s):  
Leonardo G. Ferreira ◽  
Glaucius Oliva ◽  
Adriano D. Andricopulo

Sign in / Sign up

Export Citation Format

Share Document